XL-418
XL-418 is an orally active dual Akt and p70S6K inhibitor with IC50s of 1 nM for Akt1 and 2 nM for p70S6K. XL-418 inhibits the phosphorylation of ribosomal protein S6 and GSK3β. XL-418 can be used for the study of prostate carcinoma and breast cancer[1].
Product Specifications
CAS Number
871343-09-8
UNSPSC
12352005
Target
Akt; GSK-3; Ribosomal S6 Kinase (RSK)
Related Pathways
MAPK/ERK Pathway; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(C1=CC(NCCN2CCCC2)=C(C)C(N3CCN(C4=C5C(NN=C5Br)=NC=N4)CC3)=C1)CCC(F)(F)F
Molecular Formula
C26H32BrF3N8O
Molecular Weight
609.48
References & Citations
[1]Rice KD, et al. Pyrazolopyrimidines as dual Akt/p70S6K inhibitors. Bioorg Med Chem Lett. 2012 Apr 15;22 (8) :2693-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
Akt1; GSK-3β; p70S6K
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
